Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for primary interstitial lung disease specific to childhood has been reported in the published literature.
843 clinical trials registered, 235 recruiting. Interventions under study include other interventions, drug therapy, medical devices, and procedural interventions. Pipeline includes 23 PHASE4, 25 PHASE3, 31 PHASE2. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT06984679](https://clinicaltrials.gov/study/NCT06984679) |
Data assembled from 4 of 12 sources · Last updated Nov 3, 2026, 11:34 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Physical Impairments in Children With Cystic Fibrosis |
— |
Izmir Democracy University |
RECRUITING |
[NCT06377345](https://clinicaltrials.gov/study/NCT06377345) | Remote Patient Monitoring Solution for Chronic Respiratory Disease Management | NA | SingHealth Polyclinics | RECRUITING |
[NCT05286151](https://clinicaltrials.gov/study/NCT05286151) | Network Connectivity and Temporal Processing in Adolescents Who Stutter | NA | University of Michigan | RECRUITING |
[NCT00674388](https://clinicaltrials.gov/study/NCT00674388) | The Pediatric Anesthesia Quality Improvement Project | — | The Society for Pediatric Anesthesia | RECRUITING |
[NCT04278404](https://clinicaltrials.gov/study/NCT04278404) | Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) | — | Duke University | RECRUITING |
291 publications have been identified in PubMed for primary interstitial lung disease specific to childhood. Research spans Epidemiology / Natural History (37%), Review / Meta-Analysis (24%), and Other (24%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 109 | 37% |
Research summaries | 71 | 24% |
Other research | 70 | 24% |
Laboratory research | 15 | 5% |
Clinical study results | 12 | 4% |
Testing and diagnosis research | 9 | 3% |
Patient case studies | 5 | 2% |
Liffley E (2026). [PMID: 41707309](https://pubmed.ncbi.nlm.nih.gov/41707309/). *Child Abuse Negl*. [Other]
Han Q (2026). [PMID: 41360370](https://pubmed.ncbi.nlm.nih.gov/41360370/). *J Affect Disord*. [Epidemiology / Natural History]
Paquette D (2026). [PMID: 41328631](https://pubmed.ncbi.nlm.nih.gov/41328631/). *J Health Psychol*. [Basic Science / Preclinical]
Burrows CA (2026). [PMID: 42130108](https://pubmed.ncbi.nlm.nih.gov/42130108/). *Autism Res*. [Clinical Trial Publication]
Sperati A (2026). [PMID: 41182694](https://pubmed.ncbi.nlm.nih.gov/41182694/). *J Fam Psychol*. [Other]
Haisma HH (2026). [PMID: 42459214](https://pubmed.ncbi.nlm.nih.gov/42459214/). *J Nutr Sci*. [Review / Meta-Analysis]
Ali MM (2026). [PMID: 42413307](https://pubmed.ncbi.nlm.nih.gov/42413307/). *J Health Econ*. [Other]
Forsyth M (2026). [PMID: 42366161](https://pubmed.ncbi.nlm.nih.gov/42366161/). *Med J Aust*. [Epidemiology / Natural History]
Kentor RA (2026). [PMID: 41482757](https://pubmed.ncbi.nlm.nih.gov/41482757/). *Pediatric blood & cancer*. [Review / Meta-Analysis]
Seema M (2026). [PMID: 42033247](https://pubmed.ncbi.nlm.nih.gov/42033247/). *J Public Health (Oxf)*. [Epidemiology / Natural History]
AI-curated news mentioning primary interstitial lung disease specific to childhood
Updated Sep 29, 2026
A longitudinal study identifies key factors influencing health-related quality of life in childhood interstitial lung disease. This research provides insights that could inform future therapeutic strategies and patient management.
The American Thoracic Society has released updated guidelines for the classification, evaluation, and management of childhood interstitial lung disease in infancy. This guideline aims to improve clinical practices and outcomes for affected infants.
A new stepwise diagnostic classification for childhood interstitial lung disease has been successfully applied, potentially improving diagnostic accuracy and patient outcomes. This research highlights the need for refined diagnostic approaches in rare pediatric lung conditions.